COMMUNIQUÉS West-GlobeNewswire

rYojbaba Co., Ltd. Announces Pricing of $5 Million Initial Public Offering of Japanese Common Shares and Listing on Nasdaq
13/08/2025
FUKUOKA, Japan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the pricing of its initial public offering of [...]
Corza Medical ouvre un laboratoire d’innovation pour les textiles biomédicaux afin d’accélérer le développement de produits FEO
13/08/2025
TAUNTON, Royaume-Uni, 13 août 2025 (GLOBE NEWSWIRE) -- Corza Medical, l’un des principaux fabricants mondiaux de technologies chirurgicales et de composants de dispositifs médicaux, a annoncé aujourd’hui l’ouverture de [...]
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
13/08/2025
Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs [...]
Precipio Announces its Q2-2025 Financial Results
13/08/2025
Conference call to follow tomorrow, August 14 at 5 PM EST NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its 10-Q report today. The [...]
Applied Therapeutics Reports Second Quarter 2025 Financial Results
13/08/2025
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of [...]
BioSig Technologies Inc. Announces Proposed Public Offering
13/08/2025
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention [...]
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
13/08/2025
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, [...]
Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
13/08/2025
Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64- [...]
Natural Weight Loss Supplements: How PhenQ Became the Leading Alternative to Anti-Obesity Injections in 2025
13/08/2025
London, UK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PhenQ leads 2025 with a multi-action, science-informed approach to weight loss - no needles, no prescriptions, just clean, sustainable natural weight management that fits [...]
Muscular Endurance: Bodybuilders Choose CrazyBulk Bodybuilding Supplements For Peak Performance & Strength Building
13/08/2025
Discover how CrazyBulk’s legal bodybuilding supplements can enhance muscular endurance, boost strength, and speed up recovery. Learn optimal stacks, training integration tips, and where to buy authentic CrazyBulk [...]
Erdem Hospital Performs First-of-Its-Kind Spinal Revision Surgery
13/08/2025
Groundbreaking procedure restores mobility to Italian patient after years of paralysis Photo: Erdem Hospital via FL Communications ISTANBUL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital has announced the successful [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2025
13/08/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2025 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l' [...]
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
13/08/2025
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that [...]
Inotiv, Inc. to Participate in Three Investor Conferences in September 2025
13/08/2025
WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
13/08/2025
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040, [...]
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
13/08/2025
– Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with quarterly dosing [...]
American Shared Hospital Services Reports Second Quarter 2025 Financial Results
13/08/2025
Total Revenue Increased 16% Sequentially Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading [...]
Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights
13/08/2025
Continued Clinical Program Execution in the Phase 3 CoMpass Trial in Early Choroidal Melanoma and the Phase 1b/2 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) Strengthened Balance Sheet with $75 Million Equity [...]
Immatics Announces Second Quarter 2025 Financial Results and Business Update
13/08/2025
Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: One-time infusion continues to show favorable tolerability as well as strong anti-tumor activity and durability in 33 heavily pretreated patients with [...]

Pages